Calcium Channel Blockers and Gingival Bleeding

Mechanism and Clinical Presentation

Calcium channel blockers, particularly dihydropyridines, cause gingival overgrowth through altered collagen metabolism and fibroblast proliferation in gum tissue, which predisposes to bleeding 1
The gingival changes typically manifest as hypertrophy, hyperplasia, and increased bleeding tendency during routine oral hygiene 1
Cyclosporine provides evidence of this drug class effect, causing gum hypertrophy and bleeding as a frequent adverse effect that reverses upon drug discontinuation 1

Amlodipine and nifedipine are the most commonly prescribed calcium channel blockers that can cause gingival bleeding 2, 3
These medications are widely used as first-line or add-on therapy for hypertension, making this adverse effect clinically relevant 4, 5

If gingival bleeding develops in a patient on calcium channel blockers, consider switching to an alternative antihypertensive class such as ACE inhibitors, ARBs, or beta-blockers 4, 5
Maintain meticulous oral hygiene as gingival hyperplasia from calcium channel blockers worsens with poor dental care 1
The gingival changes are typically reversible upon drug discontinuation, though this must be balanced against blood pressure control needs 1

Calcium channel blockers, particularly nifedipine and amlodipine, contribute to gingival hyperplasia and associated gingivitis in patients with hypertension 6, 7

Diltiazem and verapamil can cause gingival hyperplasia, and should be avoided in transplant patients due to their effect on ciclosporin metabolism 8

The American Heart Association guidelines recommend avoiding nondihydropyridine calcium channel blockers (diltiazem, verapamil) in heart failure patients, while considering amlodipine as a safe alternative 9
Proper periodontal maintenance is necessary to prevent progression of gingival enlargement, and may involve professional scaling and root planing as first-line management 6, 7
Consultation with the prescribing physician to exchange the calcium channel blocker for another antihypertensive class may be necessary if gingival enlargement persists despite optimal oral hygiene 6, 7